TandemAI Closes $22M Series A Extension Round to Accelerate AI-Driven Drug Discovery December 1, 2025
TandemAI and Perpetual Medicines Announce Strategic Merger to Expand Physics and AI-Based Drug Discovery Capabilities July 14, 2025
TandemAI Closes $22M Series A Extension Round to Accelerate AI-Driven Drug Discovery December 1, 2025
TandemAI and Perpetual Medicines Announce Strategic Merger to Expand Physics and AI-Based Drug Discovery Capabilities July 14, 2025
